Stanley C. Erck
2015
In 2015, Stanley C. Erck earned a total compensation of $4.9M as President, CEO and Interim CFO at Novavax, a 57% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $345,000 |
|---|---|
| Option Awards | $3,924,000 |
| Salary | $575,000 |
| Other | $7,800 |
| Total | $4,851,800 |
Erck received $3.9M in option awards, accounting for 81% of the total pay in 2015.
Erck also received $345K in non-equity incentive plan, $575K in salary and $7.8K in other compensation.
Rankings
In 2015, Stanley C. Erck's compensation ranked 1,667th out of 13,638 executives tracked by ExecPay. In other words, Erck earned more than 87.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,667 out of 13,638 | 88th |
Division Manufacturing | 603 out of 5,190 | 88th |
Major group Chemicals And Allied Products | 219 out of 1,854 | 88th |
Industry group Drugs | 169 out of 1,528 | 89th |
Industry Biological Products, Except Diagnostic Substances | 29 out of 254 | 89th |
Source: SEC filing on April 30, 2018.
Erck's colleagues
We found four more compensation records of executives who worked with Stanley C. Erck at Novavax in 2015.